Foto del docente

Alberto Maria Martelli

Professor

Department of Biomedical and Neuromotor Sciences

Academic discipline: BIO/16 Human Anatomy

Publications

vai alle Pubblicazioni

Publications prior to 2004

Queste sono le pubblicazioni più recenti (2010). Per un elenco completo andare su: http://www.ncbi.nlm.nih.gov/sites/entrez e digitare : martelli am.

These are the most recent publications (2010). For a complete list, log in to PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez) and digit: martelli am.

Emerging MEK Inhibitors.

J.A. McCubrey, L.A. Steelman, S.L. Abrams, W.H. Chappell, S. Russo, R. Ove, M. Milella, A. Tafuri, P. Lunghi, A. Bonati, F. Stivala, F. Nicoletti, M. Libra, A.M. Martelli, G. Montalto, M. Cervello.

Expert Opin. Emerg. Drugs  15: 27-47, 2010.

 

Morphological and biochemical patterns in skeletal muscle apoptosis.

         A. D'Emilio, L. Biagiotti, S. Burattini, M. Battistelli, B. Canonico, C. Evangelisti, P. Ferri, S. Papa, A.M. Martelli, E. Falcieri.

        Histol. Histopathol.25: 21-32, 2010.  

 

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network and the control of normal myelopoieis.

A.M. Martelli, F. Chiarini, C. Evangelisti, C. Grimaldi, A. Ognibene, L. Manzoli, A.M. Billi, J.A. McCubrey.

Histol. Histopathol. 25: 669-680, 2010.

 

Identification of a functional nuclear export sequence in diacylglycerol kinase-ζ

C. Evangelisti, G. C. Gaboardi1, A.M. Billi, A. Ognibene, K. Goto, P.L. Tazzari, J.A. McCubrey, A.M. Martelli.

Cell Cycle  9: 384-388, 2010.

 

Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms.

A.M. Martelli, V. Papa, P.L. Tazzari, F. Ricci, C. Evangelisti, F. Chiarini, C. Grimaldi, A. Cappellini, G. Martinelli, E. Ottaviani, P. Pagliaro, S. Horn, J. Bäsecke, L.H. Lindner, H. Eibl, J.A. McCubrey.

Leukemia  24: 687-698, 2010.  

 

Inositide signaling in the nucleus: From physiology to pathology.

L. Cocco, M.Y. Follo, I. Faenza, A. M. Billi, G. Ramazzotti, A.M. Martelli, L. Manzoli , G. Weber.

Adv Enzyme Regul.: in press, 2010: PMID: 19895834.  

 

Nuclear inositide signaling in myelodysplastic syndromes.

    M. Follo, S. Mongiorgi, C. Finelli, C. Clissa, G. Ramzzotti, I. Faenza, L. Manzoli, A.M. Martelli, L. Cocco.

J. Cell. Biochem. 109: 1065-1071, 2010.  

 

Dominant Roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs.

L.S. Steelman, S. L. Abrams J. G. Shelton, W. H. Chappell, J. Bäsecke, F. Stivala, M. Donia, F. Nicoletti, M. Libra, A.M. Martelli, J. A. McCubrey.

Cell Cycle 9: 1629-1638, 2010.  

 

The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy.

S.L. Abrams, L.S. Steelman, J.G. Shelton, E.W.T. Wong, W.H.Chappell, J. Bäsecke, F. Stivala, M. Donia, F. Nicoletti, M. Libra, A.M. Martelli, J. A. McCubrey.

Cell Cycle 9: 1781-1789, 2010.  

 

 

Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

S.L. Abrams, L.S. Steelman, J.G. Shelton, W. Chappell, J. Bäsecke, F. Stivala, M. Donia, F. Nicoletti, M. Libra, A.M. Martelli, J.A. McCubrey.

Cell Cycle 9 1839-1846: in press, 2010.

 

The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis.

A.M. Martelli, C. Evangelisti, F. Chiarini, C. Grimaldi, A. Cappellini, A. Ognibene, J.A. McCubrey.

Biochim. Biophys. Acta-Mol. Cell Res. : in press, 2010.

 

         The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukaemia.

A.M. Martelli, C. Evangelisti, F. Chiarini, J.A. McCubrey.

Oncotarget  2: in press, 2010.